Am J Transplant, Volume 20, Suppl 3 Archives - Page 33 of 223 - ATC Abstracts

2020 American Transplant Congress
A Successful Kidney Transplantation from Hepatitis C NAT Positive Deceased Donor to an HIV Positive Recipient with Previous History of Treated HCV Infection
R. H. Naik, S. Shawar, H. Schaefer
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Due to a shortage of deceased donor kidney organs, increased waiting times have been associated with adverse outcomes post kidney transplantation. The recent breakthrough…
2020 American Transplant Congress
Impact of Pregnancy on Kidney Transplant Recipients: A Propensity Score-Matched Study
T. Abe, A. Taniguchi, M. Kawamura, S. Nakazawa, T. Kato, R. Imamura, N. Nonomura
Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan
*Purpose: This study aimed to evaluate whether the experience of pregnancy and delivery would be associated with poor maternal outcome among kidney transplant recipients.*Methods: A…
2020 American Transplant Congress
The Influence of Spirituality and Other Motivations on Potential Kidney Living Donors’ Decisions to Donate by Race/Ethnicity
A. Waterman¹, G. H. Kim¹, Y. Cui², O. N. Ranasinghe¹, J. L. Beaumont², D. Adey³, U. Reddy⁴, B. Campbell⁵, F. L. Weng⁶
¹Division of Nephrology, David Geffen School of Medicine, Los Angeles, CA, ²Terasaki Research Institute, Los Angeles, CA, ³UCSF Health, San Francisco, CA, ⁴UC Irvine, Irvine, CA, ⁵Cedars Sinai Medical Center, Los Angeles, CA, ⁶St. Barnabas Medical Center, Livingston, NJ
*Purpose: Few studies have explored potential kidney living donors’ motivations to donate, particularly their spirituality, and assessed whether these motivations vary by race/ethnicity.*Methods: 2576 potential…
2020 American Transplant Congress
Early Calculation of the Tacrolimus Concentration-to-Dose Ratio Does Not Predict Outcomes after Renal Transplantation
K. Schütte-Nütgen, I. Bartmann, B. Suwelack, S. Reuter
Department of Internal Medicine D, University Hospital Münster, Münster, Germany
*Purpose: There is emerging interest in the concentration-to-dose (C/D) ratio of tacrolimus (Tac) as it is linked to outcomes after renal transplantation (RTx). Recently, we…
2020 American Transplant Congress
Frailty Prior to Hospital Discharge Predicts Mortality after Cirrhosis-Related Admissions
M. Serper¹, S. Tao², P. Garren¹, D. Peyton¹, M. A. Dunn², K. Reddy¹, A. Gougol², A. Duarte-Rojo²
¹University of Pennsylvania, Philadelphia, PA, ²University of Pittsburgh, Pittsburgh, PA
*Purpose: Inpatient frailty assessment and its utility in clinical care is understudied in liver transplant (LT) candidates. Study objectives were to quantify physical frailty among…
2020 American Transplant Congress
Concurrent Final Acceptance Associated with Decreased Deceased Donor Liver Utilization
A. Robinson¹, K. Shutterly², M. Sellers³, J. Rosendale¹, D. Brockmeier⁴
¹United Network for Organ Sharing, Richmond, VA, ²Center for Organ Recovery and Education, Pittsburgh, PA, ³Emory University Hospital and LifeLink of Georgia, Atlanta, GA, ⁴Mid-America Transplant Services, St. Louis, MO
*Purpose: With broader sharing for candidates with high MELD scores, it is not unusual for liver candidates to receive offers from multiple donors. Accepting multiple…
2020 American Transplant Congress
Standardized Incidence of De Novo Hematological Malignancies after Liver Transplantation – A Meta-Analysis of Global Transplant Registries
F. Ali¹, S. Soin¹, N. Saleem², P. Myint¹, M. R. Hussain³, B. Ali², A. Khan⁴, S. Nair⁵
¹Saint Joseph Hospital, Chicago, IL, ²UT Health Science Center, Memphis, TN, ³Icahn School of Medicine at Mount Sinai, New York, NY, ⁴West Virginia University, Charleston, WV, ⁵UT Health Science Center, Methodist University Hospital Transplant Institute, Memphis, TN
*Purpose: Liver transplant (LT) recipients are at a higher risk of de novo malignancies. In this study we aim to study the distribution and incidence…
2020 American Transplant Congress
Graft versus Host Disease in Liver Transplant Recipients: A Case Series
N. Joiner, J. Dietz, K. Nava-Estevanott, L. Kerbe
Cleveland Clinic Florida, Weston, FL
*Purpose: Graft Versus Host Disease (GvHD) is a serious and potentially fatal disease that is rarely observed in solid organ transplant recipients; however, we report…
2020 American Transplant Congress
NASH is the Leading Indication for Liver Transplantation in Elderly Patients
J. A. Steggerda¹, J. Yang², V. Sundaaram², N. Alkouri³, W. Ayoub², I. K. Kim¹, M. Noureddin²
¹Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ²Hepatology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ³Gastroenterology, University of Texas Health- San Antonio, San Antonio, TX
*Purpose: Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent cause of end-stage liver disease (ESLD) and indication for liver transplantation (LT) in the United States and…
2020 American Transplant Congress
Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis
S. A. Mehta¹, A. Katz², R. Dieter², P. Jen², J. Siegfried², J. Papadopoulos², T. Lewis²
¹Infectious Diseases, NYU Langone Health, New York, NY, ²Pharmacy, NYU Langone Health, New York, NY
*Purpose: The incidence of cytomegalovirus (CMV) remains high in the first year following kidney transplantation. Valganciclovir (VGC) is commonly prescribed in the early post-operative period…